Fundraising Fox

Oncolix

Houston, US · Delaware corporation

Biotech

Founders & leadership

JD
J Donald PayneExecutive
MT
Michael T RedmanNamed on SEC filing

Board

JP
Joseph PodolskiBoard director
JY
Jerry YoukeyBoard director
DZ
Dale ZajicekBoard director

Reported raises · per SEC filings

Form D private placements

$4.9M disclosed across 3 rounds · 2015–2017

▶$250KraisedFeb 2017 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jerry YoukeyDirector
  • Dale ZajicekDirector
  • Joseph PodolskiDirector
  • Michael T RedmanExecutive Officer, Director
  • J Donald PayneExecutive Officer
Offering amount
$5M
Amount sold
$250K
Minimum investment
$50K
Sales commissions
$400K
Proceeds to insiders
$600K
Placement agents
NewBridge Securities Corporation
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$150KraisedOct 2016 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • J Donald PayneExecutive Officer
  • Dale ZajicekDirector
  • Michael T RedmanExecutive Officer, Director
  • Jerry YoukeyDirector
  • Joseph PodolskiDirector
Offering amount
$400K
Amount sold
$150K
Minimum investment
$50K
Sales commissions
$32K
Proceeds to insiders
$30K
Placement agents
NewBridge Securities Corporation
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.5MraisedJan 2015 · 5 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph PodolskiDirector
  • J Donald PayneExecutive Officer
  • Jerry YoukeyDirector
  • Michael T RedmanExecutive Officer, Director
  • Dale ZajicekDirector
Offering amount
$6.5M
Amount sold
$4.5M
Minimum investment
$25K
Proceeds to insiders
$500K
First sale
Jan 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Oncolix Initiates Patient Recruitment of Second Cohort of Prolanta™ Phase 1 Trial in Advanced Ovarian Cancer | MarketScreenermarketscreener.com · Jan 2018Oncolix, Inc. announced that it has received $0.02225 million in funding | MarketScreenermarketscreener.com · Aug 2016TETF Helps Oncolix Raise $4.2 Million to Cancer Study BioNews Texasbionews-tx.com

Frequently asked questions

How much funding has Oncolix raised?
Oncolix has disclosed $4.9M raised across 3 rounds.
Where is Oncolix headquartered?
Oncolix is headquartered in Houston, US.